Antibody fragments pose unique challenges in recovery, purification, and formulation.
Mark Wagner
Advertisement
Mark Wagner is purification technology and business development specialist at EMD Millipore, 290 Concord Road, Billerica, MA 01821.
Articles by Mark Wagner
Advertisement
Latest Updated Articles
Downstream Purification and Formulation of Fab Antibody FragmentsPublished: January 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
5
